Concepedia

Haiyan Wu

HW

Statistics

Publications

78

Citations

9.5K

H-Index

37

Active since

1994

Affiliations

Albert Einstein College of Medicine(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Royal Marsden Hospital

Kunming Institute of Botany

University of Chinese Academy of Sciences

Haiyan Wu is an author at Albert Einstein College of Medicine specializing in life sciences, oncology, and medicine.

Publications per year

1994–2024

78

Publications

78

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma

Josep Dalmau, Erdem Tüzün, Haiyan Wu et al. · Annals of Neurology · 2007 · 2.5K citations

Life Sciences, Neurology, Neuroscience +15

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

Emmanuel S. Antonarakis, Josep M. Piulats, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2019 · 706 citations · Full text

Medicine, Oncology, Pharmacology +17

Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

Josep Tabernero, Paulo M. Hoff, Lin Shen et al. · The Lancet Oncology · 2018 · 478 citations

Medicine, Oncology, Pharmacology +17

Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development

Elisa Ciraolo, Manuela Iezzi, Romina Marone et al. · Science Signaling · 2008 · 265 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 78